FDA Releases Annual Report on Postmarketing Requirements and Commitments for Drug and Biologics Firms

Summary

The US Food and Drug Administration (FDA) has released its annual report on the performance of pharmaceutical companies in meeting postmarketing requirements and commitments for approved drugs and biologics. The report is available on the FDA's website, detailing the status of postmarketing studies and clinical trials.